...
【24h】

Late coronary stent thrombosis: early vs. late stent thrombosis in the stent era.

机译:晚期冠状动脉支架血栓形成:在支架时代早期支架血栓与晚期支架血栓形成。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The incidence of coronary stent thrombosis is < 1%-2% in recent studies, with the highest-risk period considered to be the first 30 days following stent implantation. Recently, stent thrombosis after 30 days has been reported in patients undergoing brachytherapy with stenting. We reviewed the incidence of stent thrombosis causing myocardial infarction in nonbrachytherapy patients at our institution between 1 January 1996 and 30 November 1999. A case control methodology was employed with a 1:3 ratio of stent thrombosis to control patients. Of 1,191 patients undergoing coronary stenting, acute (< 24 hr) plus subacute (1-30 days) stent thrombosis occurred in 0.92% (11 of 1,191 patients). A further 0.76% (9 of 1,191 patients) developed late stent thrombosis after 30 days. There were no clinical or angiographic features at the time of the initial procedure that were associated with stent thrombosis as an entire group compared with control group, but early (acute and subacute) stent thrombosis patients had a smaller final stent minimal lumen diameter and longer stent length compared with patients who had late stent thrombosis or controls. Late stent thrombosis occurs in nonbrachytherapy patients and is almost as frequent as early stent thrombosis. Further studies are required to determine whether longer-term poststent pharmacological treatment may decrease or prevent this complication. Copyright 2002 Wiley-Liss, Inc.
机译:在最近的研究中,冠状动脉支架血栓形成的发生率<1%-2%,其中最高的风险期被认为是支架植入后的前30天。最近,有报道称近距离放疗的患者在接受支架置入术后30天会发生血栓形成。我们回顾了1996年1月1日至1999年11月30日期间在我们机构的非近距离放射治疗患者中引起心肌梗塞的支架血栓形成的发生率。采用病例对照方法,以1:3的比例将支架血栓形成与对照患者进行比较。在1,191例接受冠状动脉支架置入术的患者中,急性(<24小时)加亚急性(1-30天)的支架血栓发生率为0.92%(1,191例患者中的11例)。 30天后,又有0.76%(1,191例患者中的9例)发生了晚期支架血栓。与对照组相比,整个手术组在初始手术时没有与支架血栓形成相关的临床或血管造影特征,但早期(急性和亚急性)支架血栓形成的患者最终支架较小,最小管腔直径较大,支架较长长度与晚期支架内血栓形成或对照的患者相比。晚期支架内血栓形成发生在非近距离放射治疗患者中,几乎与早期支架内血栓形成一样频繁。需要进行进一步的研究以确定长期的后期药理治疗是否可以减少或预防这种并发症。版权所有2002 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号